1. [1] Johann DA, Danski MTR, Vayego SA, Barbosa DA, Lind J. Risk factors for complications in peripheral intravenous catheters in adults: secondary analysis of a randomized controlled trial. Rev Lat Am Enfermagem 2016; 24. [DOI:10.1590/1518-8345.1457.2833] [PMID] [PMCID]

2. [2] Urbanetto JdS, Peixoto CG, May TA. Incidence of phlebitis associated with the use of peripheral IV catheter and following catheter removal. Rev Lat Am Enfermagem 2016; 24. [DOI:10.1590/1518-8345.0604.2746] [PMID] [PMCID]

3. [3] Tsuchida T, Makimoto K, Toki M, Sakai K, Onaka E, Otani Y. The effectiveness of a nurse-initiated intervention to reduce catheter-associated bloodstream infections in an urban acute hospital: an intervention study with before and after comparison. Int J Nurs Studi 2007; 44: 1324-1333. [DOI:10.1016/j.ijnurstu.2006.07.008] [PMID]

4. [4] Carr PJ, Rippey JC, Cooke ML, Bharat C, Murray K, Higgins NS, et al. Development of a clinical prediction rule to improve peripheral intravenous cannulae first attempt success in the emergency department and reduce post insertion failure rates: the Vascular Access Decisions in the Emergency Room (VADER) study protocol. BMJ Open 2016; 6: e009196. [DOI:10.1136/bmjopen-2015-009196] [PMID] [PMCID]

5. [5] Gallant P SA. Evaluation of a visual Infusion phlebitis Scale for determining Appropriate Discontinuation of peripheral intravenouse catheters. J Infus Nurs 2006; 26: 338-345. [DOI:10.1097/00129804-200611000-00004] [PMID]

6. [6] Miliani K, Taravella R, Thillard D, Chauvin V, Martin E, Edouard S, et al. Peripheral venous catheter-related adverse events: evaluation from a multicentre epidemiological study in france (the catheval project). PloS One 2017; 12: e0168637. [DOI:10.1371/journal.pone.0168637] [PMID] [PMCID]

7. [7] Morrison K, Holt KE. The effectiveness of clinically indicated replacement of peripheral intravenous catheters: an evidence review with implications for clinical practice. Worldviews Evid Based Nurs 2015; 12: 187-198. [DOI:10.1111/wvn.12102] [PMID]

8. [8] Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs 2015; 38: 189-203. [DOI:10.1097/NAN.0000000000000100] [PMID]

9. [9] Sharifi-Ardani M, Yekefallah L, Asefzadeh S, Nassiri-Asl M. Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial. J Integr Med 2017; 15: 373-378. [DOI:10.1016/S2095-4964(17)60358-3]

10. [10] Cicolini G, Manzoli L, Simonetti V, Flacco ME, Comparcini D, Capasso L, et al. Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi‐centre prospective study. J Adv Nurs 2014; 70: 2539-2549. [DOI:10.1111/jan.12403] [PMID]

11. [11] Mosayebi N, Shafipour SZ, Asgari F, Atrkarroushan Z, Pasdaran A. The efficacy and safety of sesame oil in prevention of chemotherapy-induced phlebitis in children with acute lymphoblastic leukemia. Iran J Pediatr Hematol Oncol 2017; 7. (Persian).

12. [12] Liu L, Su SW, Zhou P, Song R, Sun HY. External application of moisture exposed burn ointment for phlebitis: A meta-analysis of randomized controlled trials. Int J Med Medical Sci 2017; 9: 158-173. [DOI:10.5897/IJMMS2017.1310]

13. [13] Poormohamadi M, Farsi Z, Rajai N. The effect of 2% chlorhexidine gluconate solution on prevention of phlebitis related to peripheral venous catheter in patients hospitalized in cardiac care units of a military hospital. Milit Car Sci 2017; 4: 19-29. [DOI:10.29252/mcs.4.1.19]

14. [14] Kazemi M, Sabzevari S, Mohamad Alizadeh S, Razavi S. Survey of effectiveness of nitroglycerine ointment on onset of phlebitis due to peripheral catheterization in hospitalized patients at internal and surgical wards. J Kerman Univ Med Sci 1996; 3: 123-128. (Persian).

15. [15] Takaki I, Bersani-Amado L, Vendruscolo A, Sartoretto S, Diniz S, Bersani-Amado C, et al. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Medicinal Food 2008; 11: 741-746. [DOI:10.1089/jmf.2007.0524] [PMID]

16. [16] Solhi H, Salehi B, Alimoradian A, Pazouki S, Taghizadeh M, Saleh AM, et al. Beneficial effects of Rosmarinus officinalis for treatment of opium withdrawal syndrome during addiction treatment programs: a clinical trial. Addict Health 2013; 5: 90.

17. [17] Keshavarzian S, Shahgholian N. Comparison of the effect of topical application of rosemary and menthol for musculoskeletal pain in hemodialysis patients. Iran J Nurs Midwifery Res 2017; 22: 436. [DOI:10.4103/ijnmr.IJNMR_163_16] [PMID] [PMCID]

18. [18] Ince B, Yildirim AM, Okur MI, Dadaci M, Yoruk E. Effects of rosmarinus officinalis on the survivability of random-patterned skin flaps: an experimental study. J Plast Surg Hand Surg 2015; 49: 83-87. [DOI:10.3109/2000656X.2014.907172] [PMID]

19. [19] Avazeh A, Asadi Zaker M, Rasekh A, F. HH. The effect of topical using nitrogelisirin on incidence and prevalence of phlebitis indused venus catheterization. J Zanjan Med Sci Univ 2004; 12: 15-23. (Persian).

20. [20] Nito PJ, Setiawati S, Murtiningsih M. Relationship of Age, Gender, Location Insertion And Catheter Size on Incidence Phlebitis. Dinamik Kesehatan: J Kebidanan Keperawatan 2018; 8: 365-375.

21. [21] Yousefi M, Barikbin B, Kamalinejad M, Abolhasani E, Ebadi A, Younespour S, et al. Comparison of therapeutic effect of topical Nigella with Betamethasone and Eucerin in hand eczema. J Eur Acad Dermatol Venereol 2013; 27: 1498-1504. [DOI:10.1111/jdv.12033] [PMID]

22. [22] Von Schoen-Angerer T, Deckers B, Henes J, Helmert E, Vagedes J. Effect of topical rosemary essential oil on Raynaud phenomenon in systemic sclerosis. Complement Ther Med 2018; 40: 191-194. [DOI:10.1016/j.ctim.2017.10.012] [PMID]

23. [23] Beigh OA, Rahaman H. Efficacy of topical heparin in preventing the incidence of thrombophlebitis after peripheral intra venous cannulation. IOSR J Dent Med Sci 2016; 15: 50-54. [DOI:10.9790/0853-150725054]

24. [24] Eghbali-Babadi M, Ghadirian R, Hosseini SM. The effect of saline lock on phlebitis rates of patients in cardiac care units. Iran J Nurs Midwifery Res 2015; 20: 496-501. [DOI:10.4103/1735-9066.161006] [PMID] [PMCID]

25. [25] Slusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. J Am Assoc Nurse Pract 2008; 20: 172-180. [DOI:10.1111/j.1745-7599.2008.00305.x] [PMID]

26. [26] Nikfarid L, Khogasteh N, Ghanbarian A. Investigation of relation between dwell time of peripherally intravenous catheters in hospitalized neonates and children. J Hayat 2006; 12: 17-25. (Persian).

27. [27] Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 2002; 113: 146-151. [DOI:10.1016/S0002-9343(02)01163-4]

28. [28] Hosseinzadeh E, Khakshour A, Shakeri AR, Ahmadi A, Lashkardoost H. Routine versus clinically indicated replacement of intravenous atheter complications in children: a Randomized Clinical Trial. J North Khorasan Univ Med Sci 2014; 6: 269-275. (Persian). [DOI:10.29252/jnkums.6.2.269]

29. [29] Musarezaie M, Momeni-Ghaleghasemi T, Naji-Esfahani H, N. A. Determine the infection facilitators in peripheral IV catheter in viewpoint of nurses in medical-surgical wards in hospitals, Isfahan University of medical sciences. J Health Syst Res 2013; 9: 1117-1127. (Persian).